IL318600A - תכשירים ושיטות למניעת שיטיון הנגרם ממחלות ניווניות - Google Patents
תכשירים ושיטות למניעת שיטיון הנגרם ממחלות ניווניותInfo
- Publication number
- IL318600A IL318600A IL318600A IL31860025A IL318600A IL 318600 A IL318600 A IL 318600A IL 318600 A IL318600 A IL 318600A IL 31860025 A IL31860025 A IL 31860025A IL 318600 A IL318600 A IL 318600A
- Authority
- IL
- Israel
- Prior art keywords
- prevention
- compositions
- methods
- degenerative diseases
- cognitive decline
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263393555P | 2022-07-29 | 2022-07-29 | |
| PCT/US2023/071251 WO2024026480A1 (en) | 2022-07-29 | 2023-07-28 | Compositions and methods for prevention of cognitive decline caused by degenerative diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL318600A true IL318600A (he) | 2025-03-01 |
Family
ID=89707402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL318600A IL318600A (he) | 2022-07-29 | 2023-07-28 | תכשירים ושיטות למניעת שיטיון הנגרם ממחלות ניווניות |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4561566A1 (he) |
| JP (1) | JP2025525799A (he) |
| KR (1) | KR20250065331A (he) |
| CN (1) | CN119997948A (he) |
| AU (1) | AU2023312980A1 (he) |
| CA (1) | CA3263540A1 (he) |
| IL (1) | IL318600A (he) |
| WO (1) | WO2024026480A1 (he) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010207486B2 (en) * | 2009-01-26 | 2013-03-07 | Israel Institute For Biological Research | Bicyclic heterocyclic spiro compounds |
| GR1008233B (el) * | 2013-03-28 | 2014-06-23 | Αλεξανδρος Δημητριου Βαμβακιδης | Βελτιωση και θεραπευτικη αξιοποιηση της συμπτωματικης αντιμετωπισης της ασθενειας του alzheimer με rivastigmine, galantamine ή donepezil, δια επιλεγμενων αμινοτετραϋδροφουρανιων που δρουν σαν μικτοι σιγμα-1/ μουσκαρινικοι προσδετες |
| EP3794345B1 (en) * | 2018-05-18 | 2025-02-26 | Anavex Life Sciences Corp. | Optimized sigma-1 agonist method of responder selection and treatment |
| US11925659B2 (en) * | 2018-10-29 | 2024-03-12 | Cyclo Therapeutics, Inc. | Methods for treating Alzheimer's disease |
-
2023
- 2023-07-28 IL IL318600A patent/IL318600A/he unknown
- 2023-07-28 CN CN202380069188.2A patent/CN119997948A/zh active Pending
- 2023-07-28 WO PCT/US2023/071251 patent/WO2024026480A1/en not_active Ceased
- 2023-07-28 JP JP2025504781A patent/JP2025525799A/ja active Pending
- 2023-07-28 CA CA3263540A patent/CA3263540A1/en active Pending
- 2023-07-28 KR KR1020257006722A patent/KR20250065331A/ko active Pending
- 2023-07-28 EP EP23847607.1A patent/EP4561566A1/en active Pending
- 2023-07-28 AU AU2023312980A patent/AU2023312980A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2025525799A (ja) | 2025-08-07 |
| CN119997948A (zh) | 2025-05-13 |
| EP4561566A1 (en) | 2025-06-04 |
| WO2024026480A1 (en) | 2024-02-01 |
| AU2023312980A1 (en) | 2025-03-06 |
| CA3263540A1 (en) | 2024-02-01 |
| KR20250065331A (ko) | 2025-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL318748A (he) | הרכבים ושיטות לעיכוב kras | |
| IL309952A (he) | הרכבים ושיטות לטיפול במלנומה | |
| IL299762A (he) | תכשירים שימושיים לטיפול במחלת שארקו-מארי-טות | |
| EP4069707A4 (en) | METHOD AND COMPOSITIONS FOR SYNTHESIS OF THERAPEUTIC NANOPARTICLES | |
| IL316049A (he) | תכשירי רוקחות של מוסונטוזומאב ושיטות לשימוש | |
| IL312583A (he) | תכשיר לטיפול ומניעה של covid-19 | |
| CA3263315A1 (en) | NEW PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATMENT FOR PSYCHIATRIC DISORDERS | |
| IL318600A (he) | תכשירים ושיטות למניעת שיטיון הנגרם ממחלות ניווניות | |
| EP4251272A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF BLEEDING DISORDERS | |
| HK40128042A (zh) | 用於预防退行性疾病引起的认知下降的组合物和方法 | |
| EP4153616A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASES | |
| IL325816A (he) | הרכבי אנדוקסיפן ושיטות לשימוש בהם וסינתיזה שלהם | |
| EP4405469A4 (en) | COMPOSITIONS FOR THE TREATMENT OF CHARCOT-MARIE-TOOTH DISEASE | |
| HK40092454A (en) | Compositions and methods for treatment of bleeding disorders | |
| HK40105820A (en) | Methods and compositions for treatment of disease | |
| EP4304624A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATING OF DISEASES | |
| HK40117310A (en) | Compositions and methods for prevention or reduction of carpa | |
| HK40115052A (en) | Compositions and methods for treatment of prion diseases | |
| MX2025006796A (es) | Composicion farmaceutica de siponimod | |
| GB202311665D0 (en) | Modification of composition | |
| IL317091A (he) | הרכבים ושיטות לטיפול ביתר טריגליצרידים בדם חמור | |
| AU2022903713A0 (en) | Compositions and methods for prevention and treatment of cardiovascular disease | |
| IL320731A (he) | הרכבים ושיטות למחלות מערכת העצבים המרכזית | |
| GB202501591D0 (en) | Compositions for treatment of ear conditions | |
| ZA202303153B (en) | Pharmaceutical composition for reducing of cardiovascular diseases |